Home » Guidelines & Policy » Hepatitis B - NICE guideline

Hepatitis B - NICE guideline

This guideline covers assessing and managing chronic hepatitis B in children, young people and adults. It aims to improve care for people with hepatitis B by specifying which tests and treatments to use for people of different ages and with different disease severities.


This guideline includes recommendations on:

Who is it for?

  • Healthcare professionals
  • Commissioners and providers
  • People with chronic hepatitis B and their families and carers

Related publications

Bermingham SL, Hughes R, Fenu E, Sawyer LM, Boxall E, Kennedy T et al. Cost-effectiveness analysis of alternative antiviral strategies for the treatment of HBeAg-positive and HBeAg-negative chronic hepatitis B in the United Kingdom. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2015; 18(6):800-809 

Sarri G, Westby M, Kelsey A, Ritchie G, Hill-Cawthorne G, Thomas H. Chronic hepatitis B in children, young people and adults: summary of the new NICE guideline. Viral hepatitis in practice. 2013; 5(2):4-7

Sarri G, Westby M, Bermingham S, Hill-Cawthorne G, Thomas H. Diagnosis and management of chronic hepatitis B in children, young people, and adults: summary of NICE guidance. BMJ. 2013; 346:f3893

Sarri G, Ritchie G, Hill-Cawthorne G. Identification, testing, and support are key in chronic hepatitis B. Guidelines in Practice. 2013; 16(11)